Control II 1529 – 3176 pg/mL
GIP Control I 23 – 47 pg/mL MCP-1 Control I 127 – 264 pg/mL
Control II 68 – 141 pg/mL Control II 355 – 737 pg/mL
GLP-1 Control
113, 349-351 (2004).
8. Plasilova, M., et al., J. Med. Genet., 41, 609-614
(2004).
VS,ST,KSS,KAA,PHC,MAM 01/19-1
2019 Sigma-Aldrich Co. LLC. All rights reserved. SIGMA-
. Invest.,
113, 349-351 (2004).
9. Plasilova, M., et al., J. Med. Genet., 41, 609-614
(2004).
DS,PHC 06/15-1
2015 Sigma-Aldrich Co. LLC. All rights reserved. SIGMA-ALDRICH is a trademark of
as LAPs 1 and 2 (lamina-associated polypeptides),
LBR (Lamin B receptor) and emerin.6 They also
interact with chromatin and nuclear pore complexes.5
Lamin A is cleaved into a 47 kDa fragment
as LAPs 1 and 2
(lamina- associated polypeptides), LBR (Lamin B
receptor) and emerin.6 They also interact with
chromatin and nuclear pore complexes.5 Lamin A is
cleaved into a 47 kDa fragment
.C, J. Clin. Invest.,
113: 349-351 (2004).
9. Plasilova, M., et al., J. Med. Genet., 41:
609-614 (2004).
Notice
We provide information and advice to our customers
on application technologies
Isolates from Patients with cystic fibrosis and use of a simple new selective medium. J. Clin.
35:3:614-619 Microbiol. (1997)
5. D.A. Henry, M.E. Campell, C. McGimpsey, A. Clarke, L. Louden, J.L. Burns
subjected to chromatin immunoprecipitation using 1 µg of purified IgG (mouse
IgG:12-371B, Rabbit IgG: 12-370) or specific antibodies (H3K4Me3: 17-614, H3K9Ac: 17-658,
Phospho-CREB: 17-10131, RNA Pol
subjected to chromatin immunoprecipitation using 1 µg of purified IgG (mouse
IgG:12-371B, Rabbit IgG: 12-370) or specific antibodies (H3K4Me3: 17-614, H3K9Ac: 17-658,
Phospho-CREB: 17-10131, RNA Pol
subjected to chromatin immunoprecipitation using 1 µg of purified IgG (mouse
IgG:12-371B, Rabbit IgG: 12-370) or specific antibodies (H3K4Me3: 17-614, H3K9Ac: 17-658,
Phospho-CREB: 17-10131, RNA Pol
y
561 Peripherin P5117 5630 PRPH M NP_006253.2 y y y
596 Presenilin-1 (S182) P7854 5663 PSEN1 P NP_000012.1,NP_015557.2 y y y
614 PTEN P7482 5728 PTEN P NP_000305.3 y n/d y
615 PTEN P3487 5728 PTEN M
y
561 Peripherin P5117 5630 PRPH M NP_006253.2 y y y
596 Presenilin-1 (S182) P7854 5663 PSEN1 P NP_000012.1,NP_015557.2 y y y
614 PTEN P7482 5728 PTEN P NP_000305.3 y n/d y
615 PTEN P3487 5728 PTEN M
y
561 Peripherin P5117 5630 PRPH M NP_006253.2 y y y
596 Presenilin-1 (S182) P7854 5663 PSEN1 P NP_000012.1,NP_015557.2 y y y
614 PTEN P7482 5728 PTEN P NP_000305.3 y n/d y
615 PTEN P3487 5728 PTEN M
ChIPAb+™ Trimethyl-Histone H3 (Lys4) -ChIP Validated Antibody and
Primer Set, rabbit monoclonal
17-614
ChIPAb+™ RNA Pol II - ChIP Validated Antibody and Primer Set 17-620
ChIPAb+™ REST - ChIP Validated
ASPP1 A4355 M y y n/d
43 ASPP2 A4480 M y y n/d
44 ATF-1 A7833 P y n/d n/d
45 ATF2 A4086 P y n/d n/d
46 phospho-ATF-2 (pThr69,71) A4095 M y y y
47 ATM A6093 M y n/d n/d
48 Anti Cy3+Cy5 C0992
NP_000304.1 P y n/d n/d
612 Protein Tyrosine Phosphatase PEST P9109 M y y y
613 PSF P2860 M y y n/d
614 PTEN P7482 5728, 50557, 19211 PTEN,Pten NP_000305.3,NP_113794.1,NP_032986.1 P y n/d y
615 PTEN P3487
NP_000304.1 P y n/d n/d
612 Protein Tyrosine Phosphatase PEST P9109 M y y y
613 PSF P2860 M y y n/d
614 PTEN P7482 5728, 50557, 19211 PTEN,Pten NP_000305.3,NP_113794.1,NP_032986.1 P y n/d y
615 PTEN P3487